Background
Lagerstroemia speciosa (L.) is popularly called as “Jarul” in West Bengal, India and it belongs to the family Lythraceae. It is known as Pride of India, and also called Queen’s Flowers or Queen Crape Myrtle in English. This plant is widely distributed in the South East-Asian countries, Philippine and India [
1]. In India,
L.speciosa is highly abundant in the Western and Eastern Ghats and sub-tropical Himalayan regions; flowers are produced in excess by the plant (Additional file
1: Figure S1) for a short period of time but remains unutilized or underutilized. However, the people of South-east Asia used the leaves of
L. speciosa for the treatment of diabetes mellitus and obesity [
2]. The aqueous extract of leaves of
L. speciosa leaves possess potent antioxidant and free radical scavenging activities by scavenging 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) and superoxide radical as well as inhibiting lipid peroxidation [
3]. Moreover, the bioactive phytochemicals isolated from different parts of
L. speciosa, have revealed hypoglycemic, antibacterial, anti-inflammatory, antioxidant and hepato protective properties [
4‐
9]. Flowers of several plants were reported as good source of phenolic compounds and antioxidants, and also reported for treating some chronic diseases reported by earlier authors [
10]. In Philippines, the decoction of flowers of
L. speciosa is used as diuretic and also for treating fevers [
11,
12]. Hence, in this study we opted to explore the pharmacological properties of the flower extract of
L. speciosa.
The mechanisms of generation of Reactive Oxygen Species (ROS), and scavenging of ROS, operate within living cells. However, damages are inflicted on several cellular macromolecules when there is an imbalance between the generation of ROS and the rate of scavenging. ROS have direct and indirect relationships with oxidation of cellular biomolecules resulting in many health disorders such as neurodegenerative disease, hypertension, inflammation, diabetes, cancer and aging [
13]. Living organisms respond to ROS by producing antioxidant enzymes as well as they possess genetically regulated adaptive mechanisms against ROS. However, once the free radicals and ROS overwhelm the regulatory ability of the body, a state of oxidative stress ensues. Supplementation of anti-oxidants, in the normal diet, helps control the ROS-mediated macromolecular damages [
14]. The use of natural compounds as complementary and alternative drug is on rise due to the lesser side effects compared to synthetic drugs. At present, natural antioxidants are also used as alternative to synthetic antioxidants in the cosmetic, pharmaceutical and in the food industries [
15]. Moreover, presence of considerable quantity of antioxidants in Plant Part Extract (PPE) has always been a dependable clue for the investigators to hypothesize its usefulness in prevention and/or treatment of human diseases in which free radicals and other ROS have been associated. Therefore, hepatoprotective potentiality of PPE is generally evaluated against CCl
4- induced liver damages in murine model [
16,
17]. Several lead chemicals like silymarin, β-sitosterol, betalain, neoandrographolide, phyllanthin, andrographolide, curcumin, picroside, hypophyllanthin, kutkoside, and glycyrrhizin that have demonstrable hepatoprotective properties, were characterized from several PPEs [
18]. High antioxidant activity in flower extracts of different plants such as
Tecoma stans,
Hibiscus sabdariffa,
Calendula officinalis, and
Crocus sativus, were screened for hepatoprotective activity by the previous research and proved viable. [
19‐
22].
In the present study, in vitro antioxidant potential of 80% ethanolic extract of flower of
L. speciosa was determined in addition to the quantification of phenolic and flavonoid contents. Prevention of hepatic cell damage by flower-extract in CCl
4-intoxicated mice was demonstrated. Cytotoxicity tests of the flower-extract were conducted using murein spleenocytes and cancareous cell lines, MCF7 and HepG2. Since flower extract was found safe in cell-line study, we propose a future development of a suitable health drink from
L. speciosa petals, a widely accessible natural bio-resource (Additional file
2: Figure S2).
Methods
The flowers were collected in the month of March (average number of flowers per tree remain higher than February or April) 2014, from Lagerstroemia speciosa (Jarul) trees within the campus of North Bengal University, West Bengal, India. The tree (Accession number- 10512) was authenticated by the Department of Botany, North Bengal University. The petals of the flower were separated and washed thrice with distilled water to remove dust. The washed petals were sun dried and treated at 50 °C for two hours to eliminate moisture. Dried petals were then milled with a grinder (Maharani, India, Model –Sujata Dynamix). The fine powdered petal was stored in a refrigerator at −20 °C. One hundred gm of the dried powder was stirred in 1 L of 80% ethanol for 1 hour. The mixture was refluxed for 2 hours in soxhlet. After 2 hours, the mixture was centrifuged at 8000 rpm for 15 minutes. Supernatant was collected and concentrated by Rotary evaporator (45 °C) and finally freeze dried. The extract was stored in air-tight vessel at −20 °C for further studies.
Determination of antioxidant activity (in vitro)
In vitro assays
The total antioxidant, DPPH radical scavenging, hydroxyl radical scavenging, superoxide radical scavenging, nitric acid radical scavenging, singlet oxygen scavenging, reducing power, Fe
2+ chelation, peroxynitrite scavenging and hypochlorous acid scavenging activities were determined by following the previous reported methods with minor modification[
23,
24].
Determination of erythrocyte-membrane stabilizing activity
The erythrocyte membrane stabilizing activity was performed by following a standard method as described by Dey et al. [
25]. Briefly, varying concentrations of LFE (0–200 μg/ml) was added to the mixture of 50 mM phosphate buffer (0.5 ml; pH 7.2), distilled water (1 ml), 10% RBC suspension (0.25 ml PBS), 12 mM EDTA (100 μl), NBT (150 μl of 1% solution), and riboflavin (100 μl), and kept under bright light for 30 sec and incubated for 30 min at 50 °C followed by centrifugation at 1000 rpm for 10 min. The absorbance of the supernatant was measured at 562 nm. The same assay was done with the standard compound, quercetin.
Determination of total phenolic content
The total phenolics content of LFE was determined using Folin-Ciocalteu method [
23]. A standard curve prepared with known quantities of gallic acid (
R
2 = 0.9468) was used to measure the phenolic content of LFE.
Determination of total flavonoid content
The total flavonoids content was determined with aluminium chloride (AlCl
3) described by Hazra et al. [
23]. The flavonoid content was ascertained from the standard curve prepared with known quantities of quercetin (
R2 = 0.9947).
Determination of cytotoxicity
MTT Cytotoxicity assay for murine spleenocytes
The spleen was separated from a sacrificed Swiss albino mice. Cell suspension (2 × 106 cells/ml) was prepared in RPMI- 1640 medium supplemented with 50 U/ml penicillin, 50 U/ml streptomycin, 50 U/ml nystatin and 10% FBS as per reported method.EZcount ™ MTT Cell Assay Kit (HiMedia CCK003) was used, following manufacturers instruction, to determine the cytotoxicity. The percentage of cytotoxicity was calculated using the formula: (Y – X) ÷ Y × 100 [where Y is the mean optical density of the control (DMSO treated cells); and X is the mean optical density of the treated cells with LFE].
Determination of effect of LFE on cancerous cells following MTT assay
The effect of LFE on cancerous cell lines was measured using a known MTT-assay protocol as described by Denizot & Lang [
26] but with minor modifications. Two different cancerous cells, human breast adenocarcinoma cell line (MCF 7) and human hepatocarcinome cell line (HepG
2) were obtained from National Centre for Cell Science, Pune, India. Both the cell lines were treated with different concentrations of LFE in this study.
Determination of in-vivo antioxidant activity of LFE
Maintenance of Swiss albino mice
Swiss albino mice (6–8 weeks) of both sexes (equal number of mice from each sex) were maintained individually (one animal per cage in order to prevent aggression, if any, of one towards the other of the same sex or opposite) inside the cage bins (Tarson, India) with rice husk bedding in the animal enclosure of the Department of Biotechnology, University of North Bengal by maintaining proper photoperiod (12 h), temperature (25 ± 20 C) and humidity (55 ± 5%). The animals were provided pellet food (Pranav Agro Pvt. Ltd. India) and filtered (Aquaguard Eureka Forbes) tap water ad libitum. All experiments were approved by the ethical committee University of North Bengal (NO.840/ac/04 CPCSEA; date: 15.09.2010).
Determination of acute toxicity of LFE
Acute toxicity of LFE was studied following OECD in full guidelines (test 423: Acute oral toxicity – Acute toxic class method; 2002) [OECD Library]. Mice were divided into four groups (n = 6) and fasted overnight prior to the experiment. LFE was administered orally at 250, 500, 1000 and 1500 mg/kg body weight (bw) dose. The experimental mice were carefully observed for development of any clinical or toxicological symptoms at different time-period, 0.5, 2, 4, 8, 24 and 48 h.
CCl4 intoxication of experimental mice followed by treatment with LFE or silymarin
Swiss albino mice, male or female, were randomly distributed into 5 groups (n = 6) and for consecutive 10 days they received treatments once per day as per design illustrated below.
The group that received normal saline was used as control. The other groups were : (i) CCl4 group which received 1:1 (v/v) CCl4 in olive oil; (ii) Silymarin group that received 1:1 (v/v) CCl4 in olive oil and 100 mg/kg bw silymarin; (iii) Lower dose (LD) of LFE treated group which received 1:1 (v/v) CCl4 in olive oil and 100 mg/kg bw LFE; and (iv) higher dose (HD) of LFE treated group which received 1:1 (v/v) CCl4 in olive oil and 250 mg/kg bw LFE.
After cardiac punctures of the anesthesized mice (for collection of blood) made on 11th day (i.e. 24 h after the last treatment), the animals were sacrificed. Blood was allowed to clot for 60 min at room temperature (20 °C) and then serum was separated by centrifuging at 1000 rpm for 5 min. Serum was used to study marker enzymes specific to liver. The liver was surgically removed from the anesthesized animals after the cardiac puncture and before the final sacrifice. Surgically separated livers were washed with double distilled water to remove blood and homogenized tissues were used for antioxidant enzymatic assays. Liver tissues were collected in Bouin’s solution for histological studies.
Liver function test
The serum samples from each group were used to study Acid Phosphotase (ACP), Alkaline phosphatise (ALP), Aspartate aminotransferase (AST), Alanine aminotransferase (ALT) and total protein using commercially available kits (Biosystems; 11548, 11592, 11830, 11832, 11800).
Determination of Catalase activity (CAT), lipid peroxidation activity (LPO) and reduced Glutathione (GSH) determination
CAT activity was measured by the method described by earlier authors [
27]. Lipid peroxidation was quantified by thiobarbituric acid (TBA) reaction with malondialdehyde (MDA). The amount of MDA was assessed by measuring the absorbance of supernatant at 540 nm at room temperature against an appropriate blank [
27]. Glutathione was determined by the modified method of Ellman [
28].
Histological studies
Livers were removed from the animals of the in vivo experiments after collection of blood and were fixed overnight in 10% buffered formalin. The samples were subjected to dehydration and the embedded in paraffin. Thin sections (4 μm) of the paraffin embedded livers were cut by microtome and then de-waxed in xylene, rehydrated in a series of different grades of alcohol and then washed with distilled water for 5 min. Subsequently, the sections were stained with haematoxylin for 40 s and counterstained with eosin for 20 s. The sections were dehydrated in graded alcohol series and washed in xylene. The slides were observed using Magnus trinocular microscope MLX-TR (Olympus microscopes) for signs of necrosis, portal inflammation, vascular congestion, fatty infiltration, vacuolar degeneration, leukocyte infiltration, loss of structure of hepatic nodules and so forth.
Spectroscopic characterization of LFE
All UV–vis spectra were recorded in the range of 200–800 nm at room temperature with UV-1700 Spectrometer (Jasco Make, Tokyo, Japan). IR spectra of LFE obtained with Shimadzu FT-IR (Japan) were monitored by mulling in KBr. The Energy-dispersive Spectroscopy (EDS) was done with JEOL Model JED – 2300 to analyse the presence of different elements in the LFE.
GC–MS analysis of LFE
LFE was dissolved in n-hexane and the mixture was centrifuged thrice at 12,000 rpm for 15 min. The clear supernatant was used for GC–MS analysis. Agilent 5975 CGCMS system (Agilent Technologies, USA) attached with HP-5 ms Capillary Column (30 m × 0.25 mm i.d. × 0.25 μm film thickness) and equipped with inert MSD triple axis mass detector condition edation trap 200 °C, transfer line 280 °C, electronenergy70eV (vacuum pressure-2.21e-0.5 Torr) was used for analysis. The carrier gas, helium, was used at a flow rate of 1 ml/min. 2 ml sample was injected in a split less mode. The column temperature was set at 60 °C for 1 min followed by 5 °C/min up to 250 °C. The major and essential compounds in LFE were identified by the retention times and mass fragmentation patterns using Agilent Chem Station integrator and the database of National Institute of Standard and Technology (NIST) with a MS library version2011.
Statistical analysis
Assays were carried out in triplicate for all the experiments. The results are expressed as mean and standard deviation values (mean ± SD). Differences between means were determined by the analysis of variance (ANOVA), which were analyzed with SPSS v. 1. Paired ‘t’ test was done using Ky plot 5.0 (kyplot.software.informer.com/5.0/).
Discussion
Interest in antioxidants of natural origin as food and health supplements has increased much because of their potential to prevent and to reduce the risk of several diseases without any toxic effect [
29]. The plant species,
L. speciosa (L.) Pers, in the 1990’s, has attracted attention of the scientists worldwide because of its special therapeutic properties particularly for diabetes, obesity, and renal disorders [
30,
31]. Although, different vegetative parts as well as seeds of this plant were explored for potential antioxidant agents [
6,
7] but, only a single report exists that has mentioned the antioxidant activity of
L. speciosa flowers [
32]. Generally, antioxidant activities present in the plant extracts are studied with reference to hydrogen atom transfer (HAT), single electron transfer (ET), reducing power, and metal chelation assays [
33]. Therefore, in the screening of antioxidant activity of LFE, it showed strong scavenging capacity against DPPH radical, singlet oxygen, superoxide radical, NO- radicals and hydroxyl radical in a dose dependent way (Fig.
1 and Table
1). Total antioxidant activity of LFE’s was found similar to trolox (standard compound) in neutralizing the radical cation ABTS
•+ (Fig.
1a). Hypochlorous acid is known to get produced from the site of inflammation resulting from the oxidation of Cl
− ions by the neutrophil enzyme, myelo-peroxidase. The radical, HOCl is known to degrade heme-prosthetic group and inactivate the antioxidant enzyme, catalase. The HOCl scavenging activity of the LFE corresponded with the inhibition of catalase deactivation (Fig
1i and Table
1).
Reducing power is also one of the measures to confirm antioxidant activity and thus could serve as an indicator of potential antioxidant activity [
34]. In this study, the reducing power of LFE was found comparable with standard compound ascorbic acid (Fig.
1k). It was conjectured that compounds with chelating activity can inhibit lipid peroxidation by stabilizing transition metals. Our results have indicated that the chelating effect of LFE would be at least partly beneficial in protecting against oxidative damage, but not efficient as EDTA. The results also showed that LFE could protect erythrocyte membrane stabilizing activity better than the standard compound quercetin by means of scavenging superoxide radicals (Table
1).
Our results revealed the presence of high contents of phenolic and flavonoids in LFE, which is similar to an earlier report [
32]. Phenolics and flavanoid compounds are capable of scavenging singlet oxygen and various free radicals [
35]. They may also help to prevent diseases associated with oxidative stress, such as atherosclerosis, cancer and neurodegenerative diseases [
36]. In this study, results of cytotoxic activity in murine spleenocytes and human MCF 7 and HepG2 cell lines have shown no inhibition in growth, thus ruling out toxic effect of LFE on mammalian cells (data not shown). Taken together all the results, we may say with caution that LFE is perhaps safe for human consumption.
Moreover, it is essential to confirm in vitro results with in vivo assays. A common hepatotoxin, CCl
4, is generally used to induce hepatic damage in animal model to understand the extent of tissue damages for correlating conditions that happen in human beings during acute hepatitis [
37]. In this perspective, we have used mice as a model animal to check CCl
4-induced hepatoxicity and subsequent hepato-protection with the aid of LFE. When mice is fed with CCl
4, cytochrome P450 (liver enzyme) metabolises it to two trichloromethyl radicals, CCl
.
3 and CCl3OO
., by cleaving the carbon chloride bond of carbon tetrachloride [
38]. The trichloromethyl radicals generated from CCl
4 initiate free radical-mediated lipid peroxidation, which in turn leads to the accumulation of oxidation products causing apoptosis or necrosis in liver tissues [
39]. We have found that LFE can heal CCl
4 induced damaged liver in mice (Fig.
3). In case of acute hepatic damage (due to toxicity) in human beings, silymarin, an antioxidant flavanoid, is prescribed as a healing agent [
40,
41]. The same compound, sylmarin, was used as the control preventive agent in our experiment. Results have shown that exposure to CCl
4 caused significant difference in body, liver and relative liver weights with respect to the control group. Reduction in body weight and increment in liver weight took place in CCl
4 intoxicated mice with respect to the control group. Due to CCl
4 toxicity, relative liver weight of CCl
4 treated mice was found much higher than the control (Table
2). It is known that liver weight generally increases due to hepatic damage inflicted by trichloromethyl radical [
42]. Liver weight may also increase due to consequent liver fibrosis; and hypertrophy could therefore arise due to accumulation of glycogen in hepatocytes [
43]. Hence, changes in body and liver weight after CCl
4 intoxication provides direct evidence to the overall hepatic damage. Treatment with LFE (250 mg/kg body weight) has significantly prevented subsequent liver enlargement in mice. Lowering of liver or relative liver weight in LFE treated mice compared to CCl
4 group reflected prevention of fatty liver formation on CCl
4 toxicity. On other hand, weight gain was restricted in LFE treated group as compared to control (untreated) groups (Table
2), for which no definite explanation could be made; and it may be due to presence of some anti-diabetic and anti obesity compounds in LFE.
It is known that in case of extensive hepatic damages, enzymes, like AST and ALT, leave the confinement (within liver tissue) and escape into the circulatory system [
44,
45]. Hence, we have studied the levels of AST and ALT in the serum of the diseased mice compared to the untreated control. Serum AST and ALT levels were found to increase markedly in CCl
4 intoxicated mice clearly indicating altered permeability of membranes and hepatotoxicity. Interestingly, the level of AST and ALT were significantly reduced by administration of LFE (Table
3). Thus it was revealed that LFE can increase the structural integrity/stabilization of plasma membrane, which also supported the in-vitro erythrocyte membrane stabilizing activity. Moreover, restoration of structural cell integrity in case of treatment with LFE was supported by histology (by comparing the histological sections, Fig.
3). To understand more about the hepatoprotective effect rendered by LFE, the total protein concentration was measured. Total protein level, which came down, in CCl
4 intoxicated mice was partially restored by treatment with LFE. The role of antioxidant activities of LFE in vivo was studied by measuring activities of antioxidant enzymes catalase (CAT) and the levels of GSH and TBARS in the liver. TBARS (markers of lipid peroxidation) is used as a main marker of hepatocellular injury [
46]. Moreover, peroxidation of polyunsaturated fatty acids at the cell membrane leads to a cytotoxic by-product, malondialdehyde (MDA). During oxidative stress in liver, the amount of MDA determines the extent of oxidative damage [
47]. A lower MDA value in liver tissue of mice indicated a stronger protective activity in samples. Our results have shown higher concentration of MDA in CCl
4 treated group while silymerin or LFE (High dose) group significantly reversed these changes through reduction of lipid peroxidation and decreased production of free radical derivatives. This inference was substantiated by the observed decreased level of TBARS. GSH (non-enzymatic antioxidants) is the major non-protein thiol that plays a vital role in maintaining the body’s antioxidant defence mechanism [
48,
49]. It was found that the level of GSH in the liver dropped down in CCl
4 intoxicated mice. It is of general perception that accessibility of the liver cells to potential antioxidant molecules may prevent gross depletion of GSH to save the organ from destruction by free radical assault. In our case, perhaps, feeding of LFE has probably played an important role in restoring the normal intracellular GSH level. Catalase is an antioxidant enzyme which promotes the degradation of H
2O
2 into water and oxygen [
50]. Inhibition of enzymatic activities like catalase activity cause accumulation of superoxide radical and H
2O
2, which attenuates a cascade of free radical formation. Catalase was found to be increased in LFE (High Dose) or silymerin treated group compared to CCl
4 treated group (Fig
2 a and b). This restoration of catalase activity in LFE indicated the potential of LFE as antioxidant and was thus comparable to the known antioxidant, silymerin. These findings have clearly indicated that LFE is capable of protecting the liver by means of improving the enzymatic and non-enzymatic antioxidant defense systems, thus significantly reducing the generation of in vivo free radicals activated by CCl
4. Histopathological observations have provided phenotypic support in favour of LFE’s hepato-protective role in curbing the intensity of damage done by CCl
4 intoxication. The occurrence of various signs of liver injury (Additional file
3: Table S1) confirmed extensive hepatic tissue damage in CCl
4 group. CCl
4 intoxication led to tissue degeneration in liver, which was clear from prominent signs of necrosis. Silymarin and LFE administration demonstrated regeneration of healthy liver tissue with much lesser signs of injury as compared to CCl
4 treated group. The microscopy has enabled to distinguish between prominent nucleus containing organized hepatocytes (control) and the deformed nucleus in ameboid overlapped hepatocytes observed in CCl
4 treated mice’s liver (Fig
3). Restoration of tissue integrity (tight packed cells) was also observed in Silymarin or LFE group. The fatty infiltrations, due to lipid peroxidation, were prominent in CCl
4 group, but found lower in silymerin or LFE (High Dose) treated ones. Nevertheless, treatment with LFE demonstrated prominent restoration in hepatocytes. The reduced cytoplasm vacuolization, mononuclear infiltration, prevention of necrosis, and normalized sinusoidal spaces established the hepatoprotective potential of LFE in recovering normal hepatic histoarchitecture.
The antioxidant components present in the LFE was correlated with GCMS data (Additional file
5: Figure S5). The phytochemicals, sitosterol, 1,2,3-benzenetriol (pyrogallol), 3-tert-butyl-4-hydroxyanisole (also known as 3-BHA), syringic acid, oxazolidine-2, 4-dione, 9,12- Octadecadienoic acid and furan-2- carboxylic acid-3-methyl- trimethyl silyl ester identified from the GCMS data (Table
4) have reported antioxidant activities [
51‐
56]. Sitosterol has anti-hepatotoxic activities which normalizes serum transminase and hepatic antioxidant enzymes in hepato-compromised animals [
55]. There may be some more phytochemicals (remained in the GCMS data beyond the known ones) in LFE which are yet to be identified as hepatoprotective agents. In one of our previous reports, it was shown that multiple constituents of a PPE may act synergistically or additively to affect the biological system [
57]. There are also other reports on using combination of compounds to gain higher therapeutic effectiveness over singly administered compound(s) [
58]. Based on this philosophy, we propose the therapeutic prospect of the flower extract of
Lagerstroemia speciosa (L.) Pers in treating liver damages (Additional file
2: Figure S2).
Acknowledgements
Authors are thankful to Sophisticated Test and Instument Centre, SAIF, Cochin University, for EDS spectra. Authors are thankful to Dibakar Choudhury and Prof. Abhaya Prasad Das, Taxonomy & Environmental Biology Laboratory, Department of Botany, University of North Bengal for identification of plant. Authors also wish to thank Vivek Kumar Ranjan for his active support. Authors are also thankful to Mr.Jayjit Sarkar, Department of English, North Bengal St. Xavier’s College, for his generous help in proofreading the manuscript.